Gene Expression Profiling of Mediastinal Gray Zone Lymphoma and Its Relationship to Primary Mediastinal B-cell Lymphoma and Classical Hodgkin Lymphoma.
Journal
Blood cancer discovery
ISSN: 2643-3249
Titre abrégé: Blood Cancer Discov
Pays: United States
ID NLM: 101764786
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
entrez:
11
9
2020
pubmed:
12
9
2020
medline:
12
9
2020
Statut:
ppublish
Résumé
Mediastinal gray zone lymphoma (MGZL) has immunopathologic features between classical Hodgkin lymphoma (cHL) and primary mediastinal thymic B-cell lymphoma (PMBL), leading to uncertainty regarding its biological relationship to these entities. We performed gene expression profiling from patients with MGZL (20), cHL (18), and PMBL (17) and show MGZL clusters between cHL and PMBL. Expression signatures reveal germinal B-cell and IFN regulatory factor 4 (IRF4) signatures were relatively low in MGZL and cHL compared with PMBL, indicating downregulation of the B-cell program in MGZL, a hallmark of cHL. T-cell and macrophage signatures were higher in MGZL and cHL compared with PMBL, consistent with infiltrating immune cells, which are found in cHL. The NFκB signature was higher in MGZL than PMBL, and like cHL, MGZL and PMBL express NFκB inducing kinase (NIK), indicating noncanonical signaling. These findings indicate that while MGZL has distinctive clustering, it is biologically closer to cHL.
Identifiants
pubmed: 32914098
doi: 10.1158/2643-3230.BCD-20-0009
pmc: PMC7478163
mid: NIHMS1580566
pii: 2643-3230.BCD-20-0009
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Pagination
155-161Subventions
Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA SC000550
Pays : United States
Déclaration de conflit d'intérêts
Disclosure of Potential Conflicts of Interest No potential conflicts of interest were disclosed.
Références
Br J Haematol. 1994 Mar;86(3):513-23
pubmed: 7519036
N Engl J Med. 2018 Apr 12;378(15):1396-1407
pubmed: 29641966
Curr Hematol Malig Rep. 2012 Sep;7(3):241-7
pubmed: 22833351
Am J Surg Pathol. 2019 Mar;43(3):341-351
pubmed: 30540571
Haematologica. 2011 Apr;96(4):558-66
pubmed: 21454882
Am J Surg Pathol. 2005 Nov;29(11):1411-21
pubmed: 16224207
N Engl J Med. 2013 Apr 11;368(15):1408-16
pubmed: 23574119
J Hematop. 2009 Dec 22;2(4):211-36
pubmed: 20309430
Blood. 2012 Nov 1;120(18):3756-63
pubmed: 22968463
Blood. 2016 May 19;127(20):2375-90
pubmed: 26980727
Blood. 2014 Sep 4;124(10):1563-9
pubmed: 25024303
J Exp Med. 2003 Sep 15;198(6):851-62
pubmed: 12975453
Mod Pathol. 2011 Dec;24(12):1586-97
pubmed: 21822207
Surg Pathol Clin. 2019 Sep;12(3):709-718
pubmed: 31352983
Blood. 1998 Aug 1;92(3):790-4
pubmed: 9680346